Results 201 to 210 of about 2,204,899 (260)

Navigating Drug-Drug Interactions in Clinical Drug Development: A Tutorial. [PDF]

Clin Transl Sci
Lohy Das J, Ajavon-Hartmann AT, Schmith VGD.   +2 more
europepmc   +1 more source

Artificial intelligence in oncology drug development and management: a precision medicine perspective. [PDF]

Front Oncol
Fang C, Zhou P, Zhang X, He Y, Yang Q.
europepmc   +1 more source

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials. [PDF]

J Natl Cancer Inst
Mainou M, Alsadhan M, Tsapa K, Visram A, Mian H, Popat R, Mai EK, Chakraborty R, Al Hadidi S, Mohan M, Szabo A, Van Oekelen O, Cliff ERS, Mohyuddin GR.   +13 more
europepmc   +1 more source

OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development. [PDF]

Antioxidants (Basel)
Curcio A, Ganino L, Valentino I, Gentile M, Alcaro S, Rocca R, Artese A, Amodio N.   +7 more
europepmc   +1 more source

Evolution of Drug Development Trends in Multiple Sclerosis: Analysis of Mainland China and Global Landscapes From 2004 to 2024. [PDF]

CNS Neurosci Ther
Chen C, Niu Z, Yang T, Zhang X, Wei R, Pang X, Liu R, Zhou Y.   +7 more
europepmc   +1 more source

Editorial: Advancement of RWD/RWE utilization for enhancing drug development and benefit/risk assessment. [PDF]

Front Pharmacol
Uyama Y, Bérard A, Chan KA.
europepmc   +1 more source

Drug development

, 2015
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug-Glycosidation and Drug Development

Mini-Reviews in Medicinal Chemistry, 2013
Ideally a drug should be administered in a form that it exerts its pharmacological action at the target site using the lowest concentration possible and without undesirable effects. Drug targeting is the approach which is followed for the purpose. Among different approaches preparation of synthetic glycosides of target drug and administering them ...
Vijay K, Kapoor, Amanpreet, Kaur
openaire   +2 more sources

Antipsychotic Drug Development

2010
Schizophrenia typically manifests itself with a wide array of symptoms--positive, negative, cognitive, and affective--and may also involve neurodevelopmental and neurodegenerative aspects. Each of these symptom dimensions may be derived from pathology at one or more receptor types, localized in different regions of the brain.
Dennis H, Kim, Stephen M, Stahl
openaire   +2 more sources